🇪🇺 produces 21% of the world’s leading biotech publications, but our share of global clinical trials fell from 18% to 9%. The #BiotechAct is our answer: faster trials, more investment, clearer rules, stronger incentives for 🇪🇺 manufacturing & better use of health data and AI. #BiotechAct #ClinicalTrials #HealthData #EU



